Pmh23 - Real-World Costs and Budget Impact of Long-Acting Injection Atypical Antipsychotics for the Management of Schizophrenia in France

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1659
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Long-Acting Atypical Antipsychotics: Characterization of the Local Tissue Response

Pharmaceutical Research
Organic ChemistryBiotechnologyMolecular MedicinePharmacologyPharmaceutical Science
2014English

Treatment Discontinuation of Long-Acting Injectables or Oral Atypical Antipsychotics Among Medicaid Recipients With Schizophrenia

Journal of Medical Economics
Health Policy
2019English

What Is the Role of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia?

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2014English

Costs in the Treatment of Schizophrenia in Adults Receiving Atypical Antipsychotics: An 11-Year Cohort in Brazil

Applied Health Economics and Health Policy
MedicineHealth PolicyEconomicsEconometrics
2018English

Budget Impact of Long-Acting Insulin Analogues: The Case in Brazil

PLoS ONE
Multidisciplinary
2016English

Both Typical and Atypical Long-Acting Injectable Antipsychotics in Bipolar Disorder: A Retrospective Chart Review

Journal of Mood Disorders
2014English

Patient Perspectives on Use of Long-Acting Antipsychotics in Bipolar Disorder: Focus on Risperidone Injection

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2010English

Corrigendum to “Use of Aripiprazole Long Acting Injection in Negative Symptoms of Schizophrenia”

Case Reports in Psychiatry
PsychiatryMental Health
2019English

Antipsychotic Monotherapy and Polypharmacy in the Naturalistic Treatment of Schizophrenia With Atypical Antipsychotics

BMC Psychiatry
PsychiatryMental Health
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy